Source:http://linkedlifedata.com/resource/pubmed/id/11335962
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2001-5-3
|
pubmed:abstractText |
Loss of heterozygosity (LOH) at the 3p region is found in up to 50% of epithelial ovarian neoplasms. The von Hippel-Lindau (VHL) gene at the 3p25 locus is one of the tumor-suppressor genes located at 3p. The role, if any, of the VHL gene locus is not clear in ovarian carcinogenesis. We analyzed primary and metastatic ovarian clear-cell carcinomas (OCCC) for LOH at 3p25 to determine its frequency and its diagnostic utility as an adjunctive tool in the differential diagnosis of metastatic clear-cell carcinomas. Microdissection followed by single-step DNA extraction and polymerase chain reaction (PCR) amplification, using two polymorphic markers flanking the VHL gene locus, was done on archival histology and cytology samples from 9 patients with metastatic OCCC. Of the informative cases, 43% of the metastatic and 50% of the primary OCCC showed LOH. LOH at the VHL gene locus is not uncommon in clear-cell ovarian carcinoma. LOH at 3p25 in cytologic specimens may be a valuable adjunct in the diagnosis of OCCC metastasis in cytologically equivocal cases. OCCC should enter the differential in clear-cell carcinomas of unknown primary that show LOH at 3p25. Published 2001 Wiley-Liss, Inc.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Ligases,
http://linkedlifedata.com/resource/pubmed/chemical/Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ubiquitin-Protein Ligases,
http://linkedlifedata.com/resource/pubmed/chemical/VHL protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Von Hippel-Lindau Tumor Suppressor...
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
8755-1039
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
328-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11335962-Adenocarcinoma, Clear Cell,
pubmed-meshheading:11335962-Chromosomes, Human, Pair 3,
pubmed-meshheading:11335962-Diagnosis, Differential,
pubmed-meshheading:11335962-Dissection,
pubmed-meshheading:11335962-Female,
pubmed-meshheading:11335962-Genes, Tumor Suppressor,
pubmed-meshheading:11335962-Humans,
pubmed-meshheading:11335962-Ligases,
pubmed-meshheading:11335962-Loss of Heterozygosity,
pubmed-meshheading:11335962-Ovarian Neoplasms,
pubmed-meshheading:11335962-Polymerase Chain Reaction,
pubmed-meshheading:11335962-Proteins,
pubmed-meshheading:11335962-Retrospective Studies,
pubmed-meshheading:11335962-Tumor Markers, Biological,
pubmed-meshheading:11335962-Tumor Suppressor Proteins,
pubmed-meshheading:11335962-Ubiquitin-Protein Ligases,
pubmed-meshheading:11335962-Von Hippel-Lindau Tumor Suppressor Protein
|
pubmed:year |
2001
|
pubmed:articleTitle |
Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues.
|
pubmed:affiliation |
Cytopathology Section, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
|
pubmed:publicationType |
Journal Article
|